Novelion Therapeutics Inc (NASDAQ:NVLN)

3.98
Delayed Data
As of Jun 15
 -0.29 / -6.79%
Today’s Change
3.08
Today|||52-Week Range
10.68
+27.56%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close4.27
Today’s open4.18
Day’s range3.94 - 4.18
Volume46,028
Average volume (3 months)41,534
Market cap$76.5M
Data as of 4:00pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)-45.20%
Earnings growth (this year)+0.31%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)+919.88%
P/E ratioNM
Price/Sales0.42
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.40+7.48%
CTSOCytosorbents Corp+0.35+2.92%
CDXCChromadex Corp+0.01+0.27%
NATRNatures Sunshine Pro...+0.35+4.00%
Data as of 4:00pm ET, 06/15/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$138.4M
Annual profit (last year)-$126.7M
Net profit margin-91.53%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer &
Executive VP
Jeffrey Hackman
Chief Financial Officer &
Senior Vice President
Michael Dennis Price
Corporate headquarters
Vancouver, British Columbia

Forecasts